Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.
作者信息
Keller Josbert J, Vehreschild Maria Jgt, Hvas Christian L, Jørgensen Simon Md, Kupciskas Jouzas, Link Alexander, Mulder Chris Jj, Goldenberg Simon D, Arasaradnam Ramesh, Sokol Harry, Gasbarrini Antonio, Hoegenauer Christoph, Terveer Elizabeth M, Kuijper Ed J, Arkkila Perttu
机构信息
Department of Gastroenterology, Haaglanden Medical Center, The Hague, The Netherlands, and Leiden University Medical Center, Leiden, The Netherlands.
Netherlands Donor Feces Bank, Leiden University Medical Center.
出版信息
United European Gastroenterol J. 2019 Dec;7(10):1408-1410. doi: 10.1177/2050640619887579. Epub 2019 Nov 14.
Abstract
摘要
相似文献
1
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.用于粪便微生物群移植的粪便应归类为移植产品，而非药物。
United European Gastroenterol J. 2019 Dec;7(10):1408-1410. doi: 10.1177/2050640619887579. Epub 2019 Nov 14.
2
A Practical Method for Preparation of Fecal Microbiota Transplantation.一种制备粪便微生物群移植的实用方法。
Methods Mol Biol. 2016;1476:259-67. doi: 10.1007/978-1-4939-6361-4_19.
3
Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications.艰难梭菌感染中的粪便微生物群移植：证据与指征
Am Fam Physician. 2017 Mar 15;95(6):351-352.
4
Fecal Microbiota Transplant: A Rose by Any Other Name.粪便微生物群移植：换个名字的玫瑰。
Am J Gastroenterol. 2019 Jul;114(7):1176. doi: 10.14309/ajg.0000000000000286.
5
Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection.通过结肠镜检查进行粪便微生物群移植治疗复发性艰难梭菌感染
J Vis Exp. 2014 Dec 8(94):52154. doi: 10.3791/52154.
6
Treatment failure of fecal microbiota transplant for pseudomembranous colitis due to coexistent cytomegalovirus colitis.由于合并巨细胞病毒性结肠炎导致的伪膜性结肠炎粪便微生物群移植治疗失败。
J Microbiol Immunol Infect. 2016 Aug;49(4):617-8. doi: 10.1016/j.jmii.2015.05.021. Epub 2015 Jun 30.
7
Fecal microbiota transplantation-early steps on a long journey ahead.粪便微生物群移植——漫长征程的早期阶段
Gut Microbes. 2017 May 4;8(3):199-204. doi: 10.1080/19490976.2017.1316447. Epub 2017 Apr 10.
8
Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations.分析活细菌有助于粪便微生物群移植的准备工作。
PLoS One. 2017 Jan 26;12(1):e0170922. doi: 10.1371/journal.pone.0170922. eCollection 2017.
9
How to Manipulate the Microbiota: Fecal Microbiota Transplantation.如何操控微生物群：粪便微生物群移植
Adv Exp Med Biol. 2016;902:143-53. doi: 10.1007/978-3-319-31248-4_10.
10
[Pharmaceutical system of fecal microbiota transplantation: Heterogeneous practices].[粪便微生物群移植的药物系统：异质性实践]
Ann Pharm Fr. 2019 Sep;77(5):435-442. doi: 10.1016/j.pharma.2019.06.001. Epub 2019 Jun 29.
引用本文的文献
1
Fecal microbiota transplantation: a tale of two regulatory pathways.粪便微生物群移植：两条监管途径的故事
Gut Microbes. 2025 Dec;17(1):2493901. doi: 10.1080/19490976.2025.2493901. Epub 2025 Apr 29.
2
Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.粪便微生物群移植百科全书：治疗 85 种疾病的有效性综述。
Chin Med J (Engl). 2022 Aug 20;135(16):1927-1939. doi: 10.1097/CM9.0000000000002339.
3
The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Infection in Italy.意大利将粪便微生物群移植作为感染治疗方法的监管方法。
Antibiotics (Basel). 2022 Apr 5;11(4):480. doi: 10.3390/antibiotics11040480.
4
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.欧洲粪便微生物群移植（FMT）的应用：一项全欧洲范围的调查。
Lancet Reg Health Eur. 2021 Jul 19;9:100181. doi: 10.1016/j.lanepe.2021.100181. eCollection 2021 Oct.
5
Stools' donor recruitment, a challenge in pandemic times.粪便捐献者招募：疫情时期的一项挑战
United European Gastroenterol J. 2021 Nov;9(9):993-994. doi: 10.1002/ueg2.12168. Epub 2021 Oct 22.
6
Regulation, risk and safety of Faecal Microbiota Transplant.粪便微生物群移植的监管、风险与安全性
Infect Prev Pract. 2020 Sep;2(3):100069. doi: 10.1016/j.infpip.2020.100069. Epub 2020 Jun 9.
7
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21 century.粪便微生物群移植治疗肠易激综合征：21 世纪的干预措施。
World J Gastroenterol. 2021 Jun 14;27(22):2921-2943. doi: 10.3748/wjg.v27.i22.2921.
8
Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.粪便微生物群移植供体筛查更新和实体器官移植受者的研究空白。
J Clin Microbiol. 2022 Feb 16;60(2):e0016121. doi: 10.1128/JCM.00161-21. Epub 2021 Jun 16.
9
Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?粪便微生物群移植：为何我们不将其视为高级治疗药品？
United European Gastroenterol J. 2021 May;9(4):519-520. doi: 10.1002/ueg2.12066. Epub 2021 May 7.
10
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.粪便银行用于粪便微生物群移植的标准化模型：多学科 UEG 工作组的共识报告。
United European Gastroenterol J. 2021 Mar;9(2):229-247. doi: 10.1177/2050640620967898. Epub 2021 Mar 9.
本文引用的文献
1
A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations.通过粪便微生物群移植传播多重耐药菌后进行的必要讨论。
Lancet Infect Dis. 2019 Nov;19(11):1161-1162. doi: 10.1016/S1473-3099(19)30545-6.
2
Cost savings following faecal microbiota transplantation for recurrent infection.粪便微生物群移植治疗复发性感染后的成本节约
Therap Adv Gastroenterol. 2019 Apr 10;12:1756284819843002. doi: 10.1177/1756284819843002. eCollection 2019.
3
Clinical Application and Potential of Fecal Microbiota Transplantation.粪便微生物移植的临床应用和潜力。
Annu Rev Med. 2019 Jan 27;70:335-351. doi: 10.1146/annurev-med-111717-122956. Epub 2018 Nov 7.
4
Efficacy of different faecal microbiota transplantation protocols for infection: A systematic review and meta-analysis.不同粪便微生物群移植方案治疗感染的疗效：一项系统评价和荟萃分析。
United European Gastroenterol J. 2018 Oct;6(8):1232-1244. doi: 10.1177/2050640618780762. Epub 2018 Jun 3.
5
The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.粪便微生物群移植作为治疗复发性或难治性感染及其他潜在适应证的应用：联合英国胃肠病学会（BSG）和医疗保健感染学会（HIS）指南。
Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.
6
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.RBX2660-A 基于微生物组的药物预防复发性艰难梭菌感染的随机、安慰剂对照临床试验结果。
Clin Infect Dis. 2018 Sep 28;67(8):1198-1204. doi: 10.1093/cid/ciy259.
7
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南：成人和儿童艰难梭菌感染：美国传染病学会（IDSA）和美国医疗保健流行病学学会（SHEA）2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):987-994. doi: 10.1093/cid/ciy149.
8
Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent infection.经鼻十二指肠管进行粪便微生物群移植治疗复发性感染的并发症、有效性及长期随访
United European Gastroenterol J. 2017 Oct;5(6):868-879. doi: 10.1177/2050640616678099. Epub 2016 Nov 2.
9
How to: Establish and run a stool bank.如何建立和运行粪便库。
Clin Microbiol Infect. 2017 Dec;23(12):924-930. doi: 10.1016/j.cmi.2017.05.015. Epub 2017 May 19.
10
Ensuring the safe and effective FDA regulation of fecal microbiota transplantation.确保美国食品药品监督管理局对粪便微生物群移植进行安全有效的监管。
J Law Biosci. 2015 Jul 6;2(2):396-415. doi: 10.1093/jlb/lsv032. eCollection 2015 Jul.
Zotero 插件